21 An open-label, single-group, phase 2 study of brentuximab vedotin as salvage therapy for males with relapsed germ-cell tumours (GCT): Results at the end of first stage (FM12GCT01)

Saved in:
Bibliographic Details
Published inEuropean urology supplements : official journal of the European Association of Urology Vol. 15; no. 3; p. e21
Main Authors Necchi, A, Magazzu’, D, Anichini, A, Raggi, D, Giannatempo, P, Nicolai, N, Colecchia, M, Paolini, B, Coradeschi, E, Tassi, E, Grazia, G, Mortarini, R, Calareso, G, Togliardi, E, Crippa, F, Salvioni, R, Gianni, A, Valagussa, P
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.03.2016
Subjects
Urology
Online AccessGet full text

Cover

More Information
ISSN:1569-9056
1878-1500
DOI:10.1016/S1569-9056(16)60023-4